Alex Gorsky

Entity type image
Type: Person
Name: Alex Gorsky
First reported 19 hours ago - Updated 19 hours ago - 1 reports
K-Y Jelly
K-Y Jelly

J&J, Up 26% YTD, Gets After Image Problems

In the wake of scandals and investigations over manufacturing gaffes, countless product recalls and questionable marketing practices, Johnson & Johnson (JNJ) is embarking on a round of corporate soul searching. The health care giant is asking employees ... [Published Yahoo! Finance - 19 hours ago]
First reported May 13 2013 - Updated May 13 2013 - 2 reports
Johnson & Johnson
Johnson & Johnson

Johnson & Johnson (JNJ) CEO Alex Gorsky: One of America's Most Trusted People?

Staying up-to-date has never been simpler. Sign up for the today! Never mind the recalls and scandals, Alex Gorsky is a man you can trust. At least this is what a new Readerâs Digest poll has found. The ceo, who presides over a company so battered by ... [Published BioSpace - May 13 2013]
First reported May 01 2013 - Updated May 01 2013 - 1 reports

Why Pharma Execs Fear Followers on Twitter

There are no Big Pharma CEOs that I know of who actively and directly engage with their stakeholders -- investors, physicians, patients -- using social media such as Twitter. There are probably many reasons for this. For one thing, they hire entire ... [Published Pharma Marketing Blog - May 01 2013]
First reported Apr 29 2013 - Updated Apr 29 2013 - 2 reports

J&J CEO vows to make OTC formidable in U.S. again

NEW BRUNSWICK, N.J. — Johnson & Johnson chairman and CEO Alex Gorsky told shareholders at the company's annual shareholder meeting that its consumer healthcare business would reclaim its prominence in the U.S. marketplace. But OTC growth will be greatest ... [Published Retailing Today - Apr 29 2013]
First reported Apr 26 2013 - Updated Apr 27 2013 - 1 reports
PETA People for the Ethical Treatment of Animals
PETA People for the Ethical Treatment of Animals

Johnson & Johnson's CEO Hosts Annual Meeting of Shareholders (Transcript)

Johnson & Johnson ( JNJ ) Annual Meeting of Shareholders April 25, 2013 10:00 a.m. ET Executives Alex Gorsky – Chairman and CEO Doug Chia – Corporate Secretary and Assistant General Counsel Analysts Justin Danhof – National Center for ... [Published Healthcare Sector and Stocks Analysis from Seek ... - Apr 26 2013]
First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Shareholders blast Johnson & Johnson management

CEO Alex Gorsky took it in stride, promising improvements and saying maker of Tylenol and Band-Aid is making progress ... [Published CBS MoneyWatch Headlines - Apr 25 2013]
First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Better-Than-Expected DJIA Dividend Surprise from Johnson & Johnson

We have now seen three Dow Jones Industrial Average components raise their dividend payouts to shareholders this week. The third is Johnson & Johnson (NYSE: JNJ), which has just declared an increase in the quarterly dividend rate of more than 8%. The ... [Published 24/7 Wall St - Apr 25 2013]
First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Johnson & Johnson (JNJ) Raises Quarterly Dividend 8.2% to $0.66; 3.1% Yield

Johnson & Johnson (NYSE: JNJ) declared a quarterly dividend of $0.66 per share, or $2.64 annualized. This is an 8.2% increase from the prior dividend of $0.61.The dividend will be payable on June 11, 2013, to stockholders of record on May 28, 2013, with ... [Published Street Insider - Apr 25 2013]
First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Johnson & Johnson Announces Dividend Increase of 8.2%

/PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared an 8.2% increase in the quarterly dividend rate, from $0.61 per share to $0.66 per share.  The increase was announced this morning at the Annual Meeting ... [Published Stockhouse Canada - Apr 25 2013]
First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

America’s Top 15 Most Highly Paid Pharmaceutical Industry CEOs of 2012

Here is a list of America’s Top 15 most highly paid CEOs in the pharmaceutical industry in 2012, drawn from this Forbes list of CEO pay . The figures are for 1-year pay. John H Hammergren – McKesson – $131.19 million George Paz – Express Scripts – $51.52 ... [Published Terrapinn - Apr 23 2013]
First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

No ‘Silver Bullet’ for Fixing Health Care: J&J CEO

It will take a combination of approaches to make health care more affordable, Johnson & Johnson CEO Alex Gorsky told CNBC's "Closing Bell" on Monday.Paying for health care in a high-quality, economical and sustainable manner is a major societal problem, ... [Published CNBC - Apr 23 2013]
First reported Apr 22 2013 - Updated Apr 22 2013 - 1 reports

Neutrogena, Listerine Help J&J Increase Sales for Q1 2013

announced sales of $17.5 billion for the first quarter of 2013, an increase of 8.5% as compared to the first quarter of 2012. Operational results increased 9.8% and the negative impact of currency was 1.3%. Domestic sales increased 11.2%. International ... [Published Global Cosmetic Industry Magazine - Apr 22 2013]

More Content

All (79) | News (63) | Reports (2) | Blogs (12) | Audio/Video (1) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
J&J, Up 26% YTD, Gets After Image Problems [Published Yahoo! Finance - 19 hours ago]
Is Johnson & Johnson Still a Good Defensive Play? [Published Wall St. Cheat Sheet - May 17 2013]
Johnson & Johnson (JNJ) CEO Alex Gorsky: One of... [Published BioSpace - May 13 2013]
Johnson & Johnson CEO One of America's Most Tr... [Published BioSpace - May 13 2013]
Lessons in Leadership [Published CNN.com - Video - May 10 2013]
Allergan, Inc. (AGN): Is It Worth Looking At? [Published InsiderMonkey.com - May 10 2013]
Friend's death in Iraq spurs agency for veterans [Published Home News Tribune - May 03 2013]
Why Pharma Execs Fear Followers on Twitter [Published Pharma Marketing Blog - May 01 2013]
J&J CEO vows to make OTC formidable in U.S. again [Published Retailing Today - Apr 29 2013]
J&J chairman pledges to restore U.S. OTC busine... [Published Drug Store News - Apr 29 2013]
Johnson & Johnson's CEO Hosts Annual Meeting of... [Published Yahoo! Finance - Apr 27 2013]
Johnson & Johnson's CEO Hosts Annual Meetin... [Published Healthcare Sector and Stocks Analysis from Seek ... - Apr 26 2013]
Shareholders blast Johnson & Johnson management [Published CBS MoneyWatch Headlines - Apr 25 2013]
Better-Than-Expected DJIA Dividend Surprise fro... [Published 24/7 Wall St - Apr 25 2013]
Johnson & Johnson (JNJ) Raises Quarterly Divide... [Published Street Insider - Apr 25 2013]
Johnson & Johnson Announces Dividend Increase o... [Published Stockhouse Canada - Apr 25 2013]
America’s Top 15 Most Highly Paid Pharmaceutica... [Published Terrapinn - Apr 23 2013]
No ‘Silver Bullet’ for Fixing Health Care: J&J CEO [Published CNBC - Apr 23 2013]
Neutrogena, Listerine Help J&J Increase Sales f... [Published Global Cosmetic Industry Magazine - Apr 22 2013]
Too Busy For Investors: IBM's Absent CEO Isn't ... [Published Seeking Alpha - Apr 21 2013]
Johnson & Johnson net dips by 10.6% to $3.5 bn ... [Published PharmaBiz - Apr 19 2013]
The life of Alice Keller – one of the first fem... [Published PMLive - Apr 19 2013]
J&J Q1 profit falls sharply [Published Business Spectator - Apr 17 2013]
Strong first quarter for J&J thanks to new prod... [Published Pharma Times - Apr 17 2013]
J&J Profit Falls 10% [Published Drug Discovery and Development - Apr 16 2013]
Johnson & Johnson Earnings Slip 10.6% [Published Industry Week - Apr 16 2013]
Johnson & Johnson (NYSE:JNJ) Earnings Indicate ... [Published Live Trading News - Apr 16 2013]
Synthes buy props up weak device sales for J [Published FiercePharma - Apr 16 2013]
Are Johnson & Johnson’s Recall Nightmares Over? [Published Wall St. Cheat Sheet - Apr 16 2013]
Are Johnson & Johnson’s Recall Nightmares Over? [Published Wall St. Cheat Sheet - Apr 16 2013]
1 2 3
In Focus
  •  
Bill Weldon, William Weldon, Howard Schultz, [more]
  •  
Johnson & Johnson, Synthes Inc, DePuy Inc, [more]
  •  
Sisters of Charity, PETA People for the Ethical Treatment of Animals, FDA Food & Drug Administration, [more]
  •  
nonprescription, Drugs, Litigation, [more]
  •  
Tylenol, Listerine, Motrin, [more]
  •  
New Brunswick (United States), Conover (United States), Philadelphia (Pennsylvania, United States), [more]
  •  
United States, Puerto Rico, Russia, [more]
  •  
Diseases, Epidemics, Medication, [more]
  •  
Autos, Banking & Financial Services, Health, [more]
BioSpace, CBS MoneyWatch Headlines, Wall St. Cheat Sheet, [more]
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Is Johnson & Johnson Still a Good Defensive Play? [Published Wall St. Cheat Sheet - May 17 2013]
With shares of Johnson & Johnson ( NYSE:JNJ ) trading at around $87.45, is JNJ an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let’s analyze the stock with the relevant sections of our CHEAT SHEET investing framework : C = Catalyst for the Stock’s Movement ...
Why Pharma Execs Fear Followers on Twitter [Published Pharma Marketing Blog - May 01 2013]
There are no Big Pharma CEOs that I know of who actively and directly engage with their stakeholders -- investors, physicians, patients -- using social media such as Twitter. There are probably many reasons for this. For one thing, they hire entire ...
Are Johnson & Johnson’s Recall Nightmares Over? [Published Wall St. Cheat Sheet - Apr 16 2013]
From one perspective, Johnson & Johnson ( NYSE:JNJ ) showed great strength in its first quarter results. For the three month period, the company announced Tuesday that it had beat Wall Street’s quarterly profit estimates thanks to significantly lower ...
Are Johnson & Johnson’s Recall Nightmares Over? [Published Wall St. Cheat Sheet - Apr 16 2013]
From one perspective, Johnson & Johnson ( NYSE:JNJ ) showed great strength in its first quarter results. For the three month period, the company announced Tuesday that it had beat Wall Street’s quarterly profit estimates thanks to significantly ...
Gorsky Gets A Haircut: J&J Cuts Executive Bonuses [Published Pharmalot - Mar 14 2013]
Citing various ‘disappointments’ and a ‘mixed’ overall performance, Johnson & Johnson lowered the bonuses given to ceo Alex Gorsky and other top execs by 10 percent. The move comes after three years of scandals, manufacturing gaffes, an FDA consent ...
1 2 3

Audio/Video

sort by: Date | Relevance
Lessons in Leadership [Published CNN.com - Video - May 10 2013]
1

Press Releases

sort by: Date | Relevance
CEO Alex Gorsky Elected Chairman of Johnson & J... [Published PR Newswire: Consumer Products & Retail - Nov 30 2012]
1
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.